Liraglutide studies: 1,219 papers with results
Page 9 of 25
- Combination Therapy With Canagliflozin Plus Liraglutide Exerts Additive Effect on Weight Loss, but Not on HbA1c, in Patients With Type 2 Diabetes.
Ali AM · Diabetes care · 2020
Randomized controlled trial · 9 results
- Health-related quality of life in people with type 2 diabetes participating in the LEADER trial.
Nauck MA · Diabetes, obesity & metabolism · 2019
Randomized controlled trial · 4 results
- Comparison of Efficacy and Safety of Liraglutide 3.0 mg in Individuals with BMI above and below 35 kg/m²: A Post-hoc Analysis.
le Roux C · Obesity facts · 2017
Randomized controlled trial · 5 results
- GLP-1-Based Therapies Have No Microvascular Effects in Type 2 Diabetes Mellitus: An Acute and 12-Week Randomized, Double-Blind, Placebo-Controlled Trial.
Smits MM · Arteriosclerosis, thrombosis, and vascular biology · 2016
Randomized controlled trial · 2 results
- Effects of DPP-4 inhibitor linagliptin and GLP-1 receptor agonist liraglutide on physiological response to hypoglycaemia in Japanese subjects with type 2 diabetes: A randomized, open-label, 2-arm parallel comparative, exploratory trial.
Yabe D · Diabetes, obesity & metabolism · 2017
Randomized controlled trial · 4 results
- Effect on the Gastrointestinal Absorption of Drugs from Different Classes in the Biopharmaceutics Classification System, When Treating with Liraglutide.
Malm-Erjefält M · Molecular pharmaceutics · 2015
Randomized controlled trial · 9 results
- Eating behavior modulates the sensitivity to the central effects of GLP-1 receptor agonist treatment: a secondary analysis of a randomized trial.
van Ruiten CC · Psychoneuroendocrinology · 2022
Randomized controlled trial · 6 results
- Cardiovascular outcomes in patients who experienced a myocardial infarction while treated with liraglutide versus placebo in the LEADER trial.
Nauck MA · Diabetes & vascular disease research · 2018
Randomized controlled trial · 1 result
- IDegLira Improves Both Fasting and Postprandial Glucose Control as Demonstrated Using Continuous Glucose Monitoring and a Standardized Meal Test.
Holst JJ · Journal of diabetes science and technology · 2015
Randomized controlled trial · 8 results
- Longitudinal Effects of Glucose-Lowering Medications on β-Cell Responses and Insulin Sensitivity in Type 2 Diabetes: The GRADE Randomized Clinical Trial.
Rasouli N · Diabetes care · 2024
Randomized controlled trial · 5 results
- A Fixed Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) Reduces Glycemic Fluctuation and Brings More Patients with Type 2 Diabetes Within Blood Glucose Target Ranges.
King AB · Diabetes technology & therapeutics · 2017
Randomized controlled trial · 7 results
- Achieving the composite endpoint of glycated haemoglobin <7.0%, no weight gain and no hypoglycaemia in the once-weekly dulaglutide AWARD programme.
Dungan KM · Diabetes, obesity & metabolism · 2016
Randomized controlled trial · 1 result
- Weight loss maintenance with exercise and liraglutide improves glucose tolerance, glucagon response, and beta cell function.
Jensen SBK · Obesity (Silver Spring, Md.) · 2023
Randomized controlled trial · 6 results
- The effects of GLP-1 based therapies on postprandial haemodynamics: Two randomised, placebo-controlled trials in overweight type 2 diabetes patients.
Smits MM · Diabetes research and clinical practice · 2017
Randomized controlled trial · 4 results
- Patient-reported outcomes in patients with type 2 diabetes treated with liraglutide or glimepiride, both as add-on to metformin.
Hermansen K · Primary care diabetes · 2010
Randomized controlled trial · 5 results
- Effects of efpeglenatide versus liraglutide on gastric emptying, glucose metabolism and beta-cell function in people with type 2 diabetes: an exploratory, randomized phase Ib study.
Hompesch M · BMJ open diabetes research & care · 2021
Randomized controlled trial · 8 results
- Effects of liraglutide plus phentermine in adults with obesity following 1 year of treatment by liraglutide alone: A randomized placebo-controlled pilot trial.
Tronieri JS · Metabolism: clinical and experimental · 2019
Randomized controlled trial · 7 results
- Growth differentiation factor-15, treatment with liraglutide, and clinical outcomes among patients with heart failure.
Sharma A · ESC heart failure · 2021
Randomized controlled trial · 1 result
- Heart rate increases in liraglutide treated chronic heart failure patients: association with clinical parameters and adverse events.
Tougaard RS · Scandinavian cardiovascular journal : SCJ · 2020
Randomized controlled trial · 4 results
- Pleiotropic effects of liraglutide in patients with type 2 diabetes and moderate renal impairment: Individual effects of treatment.
Zobel EH · Diabetes, obesity & metabolism · 2019
Randomized controlled trial · 3 results
- Improved Beta Cell Glucose Sensitivity Plays Predominant Role in the Decrease in HbA1c with Cana and Lira in T2DM.
Ali AM · The Journal of clinical endocrinology and metabolism · 2020
Randomized controlled trial · 12 results
- Pharmacokinetic Properties of Liraglutide as Adjunct to Insulin in Subjects with Type 1 Diabetes Mellitus.
Mader JK · Clinical pharmacokinetics · 2016
Randomized controlled trial · 4 results
- Changes in health-related quality of life with intensive behavioural therapy combined with liraglutide 3.0 mg per day.
Chao AM · Clinical obesity · 2019
Randomized controlled trial · 5 results
- Weight Gain Was Associated With Worsening Glycemia and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes Independent of Diabetes Medication in the GRADE Randomized Controlled Trial.
Wexler DJ · Diabetes care · 2025
Randomized controlled trial · 9 results
- Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial.
Scherbak NN · Diabetes & metabolism journal · 2023
Randomized controlled trial · 1 result
- Hepatic triglyceride content does not affect circulating CETP: lessons from a liraglutide intervention trial and a population-based cohort.
van Eyk HJ · Scientific reports · 2019
Randomized controlled trial · 3 results
- Combination GLP-1 and Insulin Treatment Fails to Alter Myocardial Fuel Selection vs. Insulin Alone in Type 2 Diabetes.
Mather KJ · The Journal of clinical endocrinology and metabolism · 2018
Randomized controlled trial · 4 results
- Impact of Glucose-Lowering Medications on Health-Related Quality of Life in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE).
Cherrington AL · Diabetes care · 2024
Randomized controlled trial · 6 results
- The effect of baseline characteristics on clinical efficacy of liraglutide in patients treated with high-dose insulin.
Pokala N · Diabetes, obesity & metabolism · 2017
Randomized controlled trial · 2 results
- RISING STARS: Effects of a GLP-1 receptor polymorphism on responses to liraglutide.
Mashayekhi M · The Journal of endocrinology · 2025
Randomized controlled trial · 7 results
- Differential Treatment Effects on β-Cell Function Using Model-Based Parameters in Type 2 Diabetes: Results From the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE).
Utzschneider KM · Diabetes care · 2025
Randomized controlled trial · 9 results
- Medication Adherence in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE).
Gonzalez JS · Diabetes care · 2026
Randomized controlled trial · 8 results
- Dapagliflozin restores odour-induced functional integration of primary olfactory cortex circuit but not olfactory-related regional brain activation in patients with type 2 diabetes: A 16-week randomised comparative study.
Li X · Diabetes, obesity & metabolism · 2025
Randomized controlled trial · 2 results
- Effect of liraglutide on markers of insulin production in persons with type 2 diabetes treated with multiple daily insulin injections.
Westman K · Journal of diabetes and its complications · 2022
Randomized controlled trial · 1 result
- Association of Hospitalizations With Randomized Glycemia-Lowering Treatment in GRADE.
Hsia DS · Diabetes care · 2025
Randomized controlled trial · 13 results
- Medication adherence to injectable glucagon-like peptide-1 (GLP-1) receptor agonists dosed once weekly vs once daily in patients with type 2 diabetes: A meta-analysis.
Weeda ER · International journal of clinical practice · 2021
Systematic review · 1 result
- The efficacy and safety of liraglutide in the obese, non-diabetic individuals: a systematic review and meta-analysis.
Zhang P · African health sciences · 2019
Systematic review · 4 results
- Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes : A Systematic Review of Randomized Controlled Trials.
Moiz A · Annals of internal medicine · 2025
Systematic review · 8 results
- Glucagon-like peptide-1 receptor agonists modestly reduced blood pressure among patients with and without diabetes mellitus: A meta-analysis and meta-regression.
Rivera FB · Diabetes, obesity & metabolism · 2024
Systematic review · 5 results
- Glucagon-Like Peptide-1 Receptor Agonists in Post-bariatric Surgery Patients: A Systematic Review and Meta-analysis.
Dutta D · Obesity surgery · 2024
Systematic review · 8 results
- Comparative efficacy of 5 sodium-glucose cotransporter protein-2 (SGLT-2) inhibitor and 4 glucagon-like peptide-1 (GLP-1) receptor agonist drugs in non-alcoholic fatty liver disease: A GRADE-assessed systematic review and network meta-analysis of randomized controlled trials.
Gu Y · Frontiers in pharmacology · 2023
Systematic review · 16 results
- Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Suboptimal Initial Clinical Response and Weight Gain Recurrence After Bariatric Surgery: a Systematic Review and Meta-analysis.
Nie Y · Obesity surgery · 2025
Systematic review · 11 results
- The efficacy and safety of glucagon-like peptide-1 receptor agonists in non-diabetic adults with overweight/obesity: An umbrella review of systematic reviews and meta-analyses.
Zamanian N · European journal of pharmacology · 2025
Systematic review · 5 results
- Liraglutide in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials.
Kalogirou MS · Clinics and research in hepatology and gastroenterology · 2021
Systematic review · 9 results
- Glucagon-like peptide 1 receptor agonists and the clinical outcomes of inflammatory bowel disease: a systematic review and meta-analysis.
Bayoumy AB · Journal of Crohn's & colitis · 2025
Systematic review · 12 results
- Combined liraglutide and metformin therapy in overweight or obese women with polycystic ovary syndrome: A systematic review and meta-analysis.
Ling J · Diabetes, obesity & metabolism · 2025
Systematic review · 21 results
- IDeglira vs insulin degludec for type 2 diabetes: a systematic review and meta-analysis.
Liu Y · Frontiers in endocrinology · 2025
Systematic review · 13 results
- Pharmacological Interventions for Weight Reduction in Patients With Schizophrenia Treated With Antipsychotics: A Systematic Review and Network Meta-Analysis.
Stogios N · JAMA psychiatry · 2026
Systematic review · 7 results
- Glucagon-like peptide-1 receptor agonists for weight management in mental illness: a network meta-analysis.
Kishi T · Translational psychiatry · 2026
Systematic review · 48 results
- Novel Amylin-Based Therapies for Weight Management in Adults With Overweight or Obesity Without Diabetes: A Network Meta-Analysis.
Kamrul-Hasan ABM · Endocrinology, diabetes & metabolism · 2026
Systematic review · 11 results